Talking Medicines

Glasgow-based Talking Medicines, the world’s first Artificial Intelligence (AI) driven patient intelligence company designed to meet the needs of pharma, has closed a £1.5 million funding round to support its ambitions for expansion into the US. Boston based life science investor Mark Ba

Glasgow-based Talking Medicines, the world’s first social intelligence company for the pharmaceutical industry, has secured a £1.1 million funding deal to scale up its AI-based data technology platform for measuring patient sentiment. Tern Plc, the investment company specialising in

Glasgow-based data tech innovator Talking Medicines has been chosen to join Tech Nation’s Applied AI 2.0 Growth Programme. Tech Nation’s growth programmes are designed to champion and support ‘the UK’s most exceptional deep tech scale-ups’ and alumni include Skyscanner,

Some of Scotland’s early-stage mission-led businesses are stepping up in the fight against COVID-19, as part of the business community’s pandemic response.

Dr Elizabeth Fairley, co-founder and COO of healthcare data startup Talking Medicines, was announced as the winner of FutureX’s Startup Summit Competition following a live pitch battle for the grand prize worth over £220,000 in front of 1,000 delegates at this year’s summ

Three leading tech for good entrepreneurs have been selected for the Startup Summit Competition final, where they will compete for a top prize worth over £220,000.